FDA – And Rx Supply Chain Resiliency – Strikeout In Senate’s Draft Pandemic Prep Bill
US FDA’s attempt to address drug shortage and supply chain weaknesses in the upcoming reauthorization of pandemic preparedness legislation looks unlikely as both chambers of Congress have now thrown wrenches in the plan.
